研发-话题@MedSci

#研发#

826篇内容 | 7080人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1300534, encodeId=838c1300534b2, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, objectTitle=实验小鼠对女性的“偏爱”和对男性的“厌恶”，直接影响了药物研发实验的结果, objectType=article, longId=737831, objectId=3e89e3783160, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3e89e3783160, replyNumber=0, likeNumber=183, createdTime=2022-09-06, rootId=0, userName=lqvr, userId=aea0290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3e89e3783160, moduleTitle=实验小鼠对女性的“偏爱”和对男性的“厌恶”，直接影响了药物研发实验的结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3e89e3783160)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1300533, encodeId=1b35130053397, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, objectTitle=上海生物医药创新企业自主研发的新冠 mRNA疫苗一期临床试验入组完毕, objectType=article, longId=735859, objectId=3eebe358592e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3eebe358592e, replyNumber=0, likeNumber=149, createdTime=2022-08-16, rootId=0, userName=lqvr, userId=aea0290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3eebe358592e, moduleTitle=上海生物医药创新企业自主研发的新冠 mRNA疫苗一期临床试验入组完毕, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3eebe358592e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1300532, encodeId=86d8130053248, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, objectTitle=靶向蛋白降解药物研发新锐企业格博生物完成A+轮融资，启明创投领投, objectType=article, longId=734232, objectId=c34ae34232df, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c34ae34232df, replyNumber=0, likeNumber=153, createdTime=2022-08-04, rootId=0, userName=lqvr, userId=aea0290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c34ae34232df, moduleTitle=靶向蛋白降解药物研发新锐企业格博生物完成A+轮融资，启明创投领投, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c34ae34232df)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1300531, encodeId=82681300531a9, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, objectTitle=华西医院研发新型人工酶，具有与万古霉素相当的抗菌性能！, objectType=article, longId=732409, objectId=15b1e32409cc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=15b1e32409cc, replyNumber=0, likeNumber=143, createdTime=2022-07-16, rootId=0, userName=lqvr, userId=aea0290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=15b1e32409cc, moduleTitle=华西医院研发新型人工酶，具有与万古霉素相当的抗菌性能！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=15b1e32409cc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1300530, encodeId=bcf71300530d7, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, objectTitle=【倒计时4天】2022中国抗病毒药物研发大会召开在即相约苏州！, objectType=article, longId=731495, objectId=483be3149517, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=483be3149517, replyNumber=0, likeNumber=168, createdTime=2022-07-08, rootId=0, userName=lqvr, userId=aea0290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=483be3149517, moduleTitle=【倒计时4天】2022中国抗病毒药物研发大会召开在即相约苏州！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=483be3149517)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1300529, encodeId=faf913005292c, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, objectTitle=【邀请函】2022中国抗病毒药物研发大会即将起航！, objectType=article, longId=730841, objectId=7983e30841db, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7983e30841db, replyNumber=0, likeNumber=135, createdTime=2022-07-01, rootId=0, userName=lqvr, userId=aea0290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7983e30841db, moduleTitle=【邀请函】2022中国抗病毒药物研发大会即将起航！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7983e30841db)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1300528, encodeId=69da130052815, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, objectTitle=优秀案例 | 脑功能环路研究的新技术方法和工具的研发与转化, objectType=article, longId=730694, objectId=ea96e30694ea, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ea96e30694ea, replyNumber=0, likeNumber=210, createdTime=2022-06-29, rootId=0, userName=lqvr, userId=aea0290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ea96e30694ea, moduleTitle=优秀案例 | 脑功能环路研究的新技术方法和工具的研发与转化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ea96e30694ea)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1300527, encodeId=d6c1130052e62, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, objectTitle=武田在ASCO和EHA上展示肿瘤学产品组合和研发产品线的最新研究成果, objectType=article, longId=728477, objectId=a6b9e2847722, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a6b9e2847722, replyNumber=0, likeNumber=129, createdTime=2022-06-03, rootId=0, userName=lqvr, userId=aea0290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a6b9e2847722, moduleTitle=武田在ASCO和EHA上展示肿瘤学产品组合和研发产品线的最新研究成果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a6b9e2847722)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1300526, encodeId=025e1300526dd, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, objectTitle=新冠疫苗研发速度如此之快，为什么HIV疫苗就这么难？, objectType=article, longId=728169, objectId=ec75e2816927, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ec75e2816927, replyNumber=0, likeNumber=153, createdTime=2022-05-31, rootId=0, userName=lqvr, userId=aea0290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ec75e2816927, moduleTitle=新冠疫苗研发速度如此之快，为什么HIV疫苗就这么难？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ec75e2816927)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1300525, encodeId=eda413005257d, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, objectTitle=物传人的概率为空气传播的千分之一，我国自主研发的mRNA疫苗获批临床试验丨新冠研究一周进展, objectType=article, longId=726406, objectId=7befe264069b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7befe264069b, replyNumber=0, likeNumber=133, createdTime=2022-05-10, rootId=0, userName=lqvr, userId=aea0290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7befe264069b, moduleTitle=物传人的概率为空气传播的千分之一，我国自主研发的mRNA疫苗获批临床试验丨新冠研究一周进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7befe264069b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1300524, encodeId=ff0e130052475, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, objectTitle=FDA 关闭 PI3K 抑制剂单臂试验的大门，会给中国新药研发带来哪些启示？, objectType=article, longId=725783, objectId=0217e25783c1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0217e25783c1, replyNumber=0, likeNumber=178, createdTime=2022-05-01, rootId=0, userName=lqvr, userId=aea0290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0217e25783c1, moduleTitle=FDA 关闭 PI3K 抑制剂单臂试验的大门，会给中国新药研发带来哪些启示？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0217e25783c1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1300522, encodeId=e94a13005224f, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, objectTitle=冰洲石生物自主研发的创新雌激素受体嵌合降解剂AC0682临床申请获国家药监局批准, objectType=article, longId=723698, objectId=a233e2369829, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a233e2369829, replyNumber=0, likeNumber=142, createdTime=2022-04-08, rootId=0, userName=lqvr, userId=aea0290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a233e2369829, moduleTitle=冰洲石生物自主研发的创新雌激素受体嵌合降解剂AC0682临床申请获国家药监局批准, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a233e2369829)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1300521, encodeId=69941300521be, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, objectTitle=亚瑟医药宣布完成数亿元人民币A轮融资，推动高端制剂研发生产及连续化生产布局，凯乘资本担任本轮融资财务顾问, objectType=article, longId=723647, objectId=ee4fe2364717, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ee4fe2364717, replyNumber=0, likeNumber=149, createdTime=2022-04-08, rootId=0, userName=lqvr, userId=aea0290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ee4fe2364717, moduleTitle=亚瑟医药宣布完成数亿元人民币A轮融资，推动高端制剂研发生产及连续化生产布局，凯乘资本担任本轮融资财务顾问, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ee4fe2364717)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1300520, encodeId=34941300520ca, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, objectTitle=首次！武汉大学研发新冠病毒快检新方法，检出率达94.2%, objectType=article, longId=301847, objectId=c00d30184ea3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c00d30184ea3, replyNumber=0, likeNumber=167, createdTime=2022-03-30, rootId=0, userName=lqvr, userId=aea0290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c00d30184ea3, moduleTitle=首次！武汉大学研发新冠病毒快检新方法，检出率达94.2%, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c00d30184ea3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1300519, encodeId=9337130051922, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, objectTitle=STTT：羟甲香豆素可能对新冠重症治疗有益！有望研发新冠口服药, objectType=article, longId=301346, objectId=bb89301346e1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bb89301346e1, replyNumber=0, likeNumber=0, createdTime=2022-03-23, rootId=0, userName=lqvr, userId=aea0290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bb89301346e1, moduleTitle=STTT：羟甲香豆素可能对新冠重症治疗有益！有望研发新冠口服药, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bb89301346e1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1300518, encodeId=2aea13005183d, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, objectTitle=国家卫健委：根据我国疫苗研发进展，可能会增加更多的加强免疫接种选择, objectType=article, longId=301105, objectId=bf03301105cd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bf03301105cd, replyNumber=0, likeNumber=140, createdTime=2022-03-20, rootId=0, userName=lqvr, userId=aea0290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bf03301105cd, moduleTitle=国家卫健委：根据我国疫苗研发进展，可能会增加更多的加强免疫接种选择, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bf03301105cd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1300523, encodeId=869c13005231b, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, objectTitle=AI赋能加速mRNA疫苗和药物研发, objectType=article, longId=300999, objectId=79f4300999e6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=79f4300999e6, replyNumber=0, likeNumber=175, createdTime=2022-03-18, rootId=0, userName=lqvr, userId=aea0290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=79f4300999e6, moduleTitle=AI赋能加速mRNA疫苗和药物研发, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=79f4300999e6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1300517, encodeId=c82e130051e0d, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, objectTitle=我国自主研发的抗新冠口服药 VV116 启动三期临床研究, objectType=article, longId=300977, objectId=fd013009e7ec, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fd013009e7ec, replyNumber=0, likeNumber=118, createdTime=2022-03-18, rootId=0, userName=lqvr, userId=aea0290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fd013009e7ec, moduleTitle=我国自主研发的抗新冠口服药 VV116 启动三期临床研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fd013009e7ec)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1300516, encodeId=3985130051625, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, objectTitle=Cell：解析HIV病毒全新画像，推动艾滋病疫苗研发, objectType=article, longId=299970, objectId=8fa92999e075, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8fa92999e075, replyNumber=0, likeNumber=0, createdTime=2022-03-04, rootId=0, userName=lqvr, userId=aea0290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8fa92999e075, moduleTitle=Cell：解析HIV病毒全新画像，推动艾滋病疫苗研发, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8fa92999e075)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1300515, encodeId=b7db1300515c5, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, objectTitle=曹彬教授：新冠抗病毒小分子药物临床研发进展, objectType=article, longId=299365, objectId=622429936518, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=622429936518, replyNumber=0, likeNumber=145, createdTime=2022-02-23, rootId=0, userName=lqvr, userId=aea0290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=622429936518, moduleTitle=曹彬教授：新冠抗病毒小分子药物临床研发进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=622429936518)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

研发

2020-05-29

lqvr (审核中...)

前往app查看评论内容

#研发#

实验小鼠对女性的“偏爱”和对男性的“厌恶”，直接影响了药物研发实验的结果

2022-09-06

lqvr (审核中...)

前往app查看评论内容

#研发#

上海生物医药创新企业自主研发的新冠 mRNA疫苗一期临床试验入组完毕

2022-08-16

lqvr (审核中...)

前往app查看评论内容

#研发#

靶向蛋白降解药物研发新锐企业格博生物完成A+轮融资，启明创投领投

2022-08-04

lqvr (审核中...)

前往app查看评论内容

#研发#

华西医院研发新型人工酶，具有与万古霉素相当的抗菌性能！

2022-07-16

lqvr (审核中...)

前往app查看评论内容

#研发#

【倒计时4天】2022中国抗病毒药物研发大会召开在即相约苏州！

2022-07-08

lqvr (审核中...)

前往app查看评论内容

#研发#

【邀请函】2022中国抗病毒药物研发大会即将起航！

2022-07-01

lqvr (审核中...)

前往app查看评论内容

#研发#

优秀案例 | 脑功能环路研究的新技术方法和工具的研发与转化

2022-06-29

lqvr (审核中...)

前往app查看评论内容

#研发#

武田在ASCO和EHA上展示肿瘤学产品组合和研发产品线的最新研究成果

2022-06-03

lqvr (审核中...)

前往app查看评论内容

#研发#

新冠疫苗研发速度如此之快，为什么HIV疫苗就这么难？

2022-05-31

lqvr (审核中...)

前往app查看评论内容

#研发#

物传人的概率为空气传播的千分之一，我国自主研发的mRNA疫苗获批临床试验丨新冠研究一周进展

2022-05-10

lqvr (审核中...)

前往app查看评论内容

#研发#

FDA 关闭 PI3K 抑制剂单臂试验的大门，会给中国新药研发带来哪些启示？

2022-05-01

lqvr (审核中...)

前往app查看评论内容

#研发#

冰洲石生物自主研发的创新雌激素受体嵌合降解剂AC0682临床申请获国家药监局批准

2022-04-08

lqvr (审核中...)

前往app查看评论内容

#研发#

亚瑟医药宣布完成数亿元人民币A轮融资，推动高端制剂研发生产及连续化生产布局，凯乘资本担任本轮融资财务顾问

2022-04-08

lqvr (审核中...)

前往app查看评论内容

#研发#

首次！武汉大学研发新冠病毒快检新方法，检出率达94.2%

2022-03-30

lqvr (审核中...)

前往app查看评论内容

#研发#

STTT：羟甲香豆素可能对新冠重症治疗有益！有望研发新冠口服药

2022-03-23

lqvr (审核中...)

前往app查看评论内容

#研发#

国家卫健委：根据我国疫苗研发进展，可能会增加更多的加强免疫接种选择

2022-03-20

lqvr (审核中...)

前往app查看评论内容

#研发#

AI赋能加速mRNA疫苗和药物研发

2022-03-18

lqvr (审核中...)

前往app查看评论内容

#研发#

我国自主研发的抗新冠口服药 VV116 启动三期临床研究

2022-03-18

lqvr (审核中...)

前往app查看评论内容

#研发#

Cell：解析HIV病毒全新画像，推动艾滋病疫苗研发

2022-03-04

lqvr (审核中...)

前往app查看评论内容

#研发#

曹彬教授：新冠抗病毒小分子药物临床研发进展

2022-02-23

科室
- - 订阅+
  - 更多科室
工具
服务